Skip to main content
logo
Xvivo Perfusion AB (publ) (STO:XVIVO)
Sweden flag Sweden · Delayed Price · Currency is SEK
268.00
-6.00 (-2.19%)
May 5, 2026, 4:29 PM CET

Revenue by Segment

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Thoracic
384.36M296.35M198.63M--
Thoracic Growth
29.70%49.20%---
Services
79.14M48.08M6.05M--
Services Growth
64.61%694.68%---
Abdominal
134.04M70.86M53.71M--
Abdominal Growth
89.16%31.94%---
Non-Durable Goods
---169.43M206.86M
Non-Durable Goods Growth
----18.10%19.78%
Durable Goods
---10.44M13.98M
Durable Goods Growth
----25.36%-7.87%
Total
597.54M415.29M258.39M179.86M220.84M
Total Growth
43.88%60.73%43.66%-18.56%17.55%

Revenue by Geography

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
USA
308.10M224.87M119.64M90.65M-
USA Growth
37.01%87.96%31.98%--
Sweden
4.22M1.67M2.29M1.31M1.17M
Sweden Growth
152.57%-27.17%75.57%12.10%-41.22%
The Netherlands
30.22M25.99M19.42M--
The Netherlands Growth
16.29%33.83%---
Italy
58.93M21.48M14.78M--
Italy Growth
174.32%45.32%---
North and South America, Excluding The US
25.62M25.49M19.03M17.48M-
North and South America, Excluding The US Growth
0.53%33.94%8.85%--
EMEA Excluding Sweden,Netherlands and Italy
128.28M96.99M69.84M--
EMEA Excluding Sweden,Netherlands and Italy Growth
32.27%38.86%---
Asia/Pacific and Oceania
42.18M18.81M13.38M--
Asia/Pacific and Oceania Growth
124.24%40.54%---
EMEA Excluding Sweden
---60.99M65.10M
EMEA Excluding Sweden Growth
----6.31%18.61%
Asia/Pacific
---9.43M16.97M
Asia/Pacific Growth
----44.41%78.95%
Americas
----137.60M
Americas Growth
----13.23%
Total
597.54M415.29M258.39M179.86M220.84M
Total Growth
43.89%60.72%43.66%-18.55%17.55%
Source: S&P Global Market Intelligence.